IL1B and neoplasm: In breast cancer bone metastasis, IL-1β from tumor cells and the microenvironment can inhibit primary tumor growth by impairing the infiltration of innate immune cells with potential anti-cancer functions, while simultaneously promoting enhanced tumor cell migration and osteolytic metastases [103].